Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier A Menendez

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Biomolecules|May 24, 2020
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and IdentityJavier A Menendez
Aging|May 29, 2020
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19Javier A Menendez
Biochimica Et Biophysica Acta|September 29, 2009
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectivesJavier A Menendez
Current Pharmaceutical Design|July 14, 2015
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology DrugsJavier A Menendez
Cell Cycle (Georgetown, Tex.)|March 5, 2015
Metabolic control of cancer cell stemness: Lessons from iPS cellsJavier A Menendez
Expert Opinion on Therapeutic Targets|September 19, 2017
Fatty acid synthase (FASN) as a therapeutic target in breast cancerJavier A Menendez, Ruth Lupu
International Journal of Molecular Medicine|December 8, 2004
RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cellsJavier A Menendez, Ruth Lupu
Endocrinology|July 1, 2006
Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?Ruth Lupu, Javier A Menendez
Current Pharmaceutical Biotechnology|December 16, 2006
Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?Ruth Lupu, Javier A Menendez
Current Pharmaceutical Biotechnology|December 16, 2006
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)Javier A Menendez, Ruth Lupu
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Biomolecules|May 24, 2020
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and IdentityJavier A Menendez
Aging|May 29, 2020
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19Javier A Menendez
Biochimica Et Biophysica Acta|September 29, 2009
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectivesJavier A Menendez
Current Pharmaceutical Design|July 14, 2015
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology DrugsJavier A Menendez
Cell Cycle (Georgetown, Tex.)|March 5, 2015
Metabolic control of cancer cell stemness: Lessons from iPS cellsJavier A Menendez
Expert Opinion on Therapeutic Targets|September 19, 2017
Fatty acid synthase (FASN) as a therapeutic target in breast cancerJavier A Menendez, Ruth Lupu
International Journal of Molecular Medicine|December 8, 2004
RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cellsJavier A Menendez, Ruth Lupu
Endocrinology|July 1, 2006
Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?Ruth Lupu, Javier A Menendez
Current Pharmaceutical Biotechnology|December 16, 2006
Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?Ruth Lupu, Javier A Menendez
Current Pharmaceutical Biotechnology|December 16, 2006
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)Javier A Menendez, Ruth Lupu
Pageof 27